Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Burden Attributable to Iodine Deficiency in Iran From 1990 to 2019: Findings From Global Burden of Disease Study Publisher Pubmed



Rasoulian P1 ; Khadembashiri MA2 ; Amlashi MA3 ; Ghazanfari S4 ; Arbatan MN5 ; Rabiei Z6 ; Danandeh K1, 7 ; Faridpour A8 ; Dehghani E1, 9
Authors
Show Affiliations
Authors Affiliations
  1. 1. Sports medicine research center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Neuromusculoskeletal Research Center, Iran University of Medical Sciences, Tehran, Iran
  3. 3. Department of Nutrition, School of Public Health, Iran University of Medical Sciences, Tehran, Iran
  4. 4. Department of Orthodontics, Dental School of Shahid Beheshti University of Medical Science, Tehran, Iran
  5. 5. Islamic Azad University, Tehran, Iran
  6. 6. Department of Food Science and Technology, Tehran Medical Sciences Branch, Islamic Azad University, Tehran, Iran
  7. 7. School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  8. 8. Arak University of Medical Sciences, Arak, Iran
  9. 9. Department of Clinical Nutrition, School of Nutrition and Dietetics, Tehran University of Medical Sciences (TUMS), Tehran, Iran

Source: Journal of Preventive Medicine and Hygiene Published:2024


Abstract

Introduction. Iodine is necessary for the synthesis of thyroid hor-mones which rely on sufficient levels of iodine. Iodine deficiency (ID) gives rise to various diseases. This is the first study present-ing the epidemiology of ID in the Iranian population from 1992 to 2019. Methods. This study was performed based on the analysis of global burden of disease (GBD) study data. Epidemiological indi-ces including prevalence, incidence, and age-standardized disa-bility-adjusted life years (DALYs) were compared in all provinces located in Iran between 1992 and 2019. Results. The studies' collective conclusions showed that Iran's age-standardized DALYs rate (ASDR) for iodine deficiency dropped from 14.76 to 5.92. Additionally, the ASDR for Iodine Deficiency is clearly trending lower for all provinces. The ASDR for iodine deficiency peaked in 1990 in middle-aged people of both sexes. But later in the year, the pattern changed, with males and older age groups in particular reporting a larger ASDR of iodine deficiency. Conclusions.The findings of this study show that the burden of iodine deficiency disorder has decreased in different provinces, all age and, males, but some provinces and groups still need more regulations to reduce the burden of iodine deficiency. © 2024 Pacini Editore Srl. All rights reserved.
Related Docs
View other Related Docs
1. Increasing Burden of Upper-Extremity Fractures in the Middle East and North Africa (Mena): A 30-Year Analysis of the Epidemiology and Causes of Injuries, Journal of Bone and Joint Surgery (2024)
2. Burden of Hand Osteoarthritis in the Middle East and North Africa (Mena): An Epidemiological Analysis From 1990 to 2019, Journal of Hand Surgery (2023)
3. Epidemiology of Brain and Other Central Nervous System Cancers in the North Africa and Middle East Region: A Systematic Analysis of the Global Burden of Disease Study 1990–2019, World Neurosurgery (2023)
4. Global, Regional, and National Burden of Migraine in 204 Countries and Territories, 1990 to 2019, Pain (2022)
5. Metabolic Risk Factors Attributed Burden in Iran at National and Subnational Levels, 1990 to 2019, Frontiers in Public Health (2023)
6. Prevalence, Deaths, and Disability-Adjusted Life-Years Due to Asthma and Its Attributable Risk Factors in 204 Countries and Territories, 1990-2019, Chest (2022)
7. The Global, Regional, and National Burden of Adult Lip, Oral, and Pharyngeal Cancer in 204 Countries and Territories: A Systematic Analysis for the Global Burden of Disease Study 2019, JAMA Oncology (2023)
8. Global, Regional, and National Burden of Rheumatoid Arthritis, 1990–2020, and Projections to 2050: A Systematic Analysis of the Global Burden of Disease Study 2021, The Lancet Rheumatology (2023)
Experts (# of related papers)
View all Related Experts
Farshad Farzadfar (28)
Bagher Larijani (28)
Other Related Docs
9. Increasing Burden of Hip Osteoarthritis in the Middle East and North Africa (Mena): An Epidemiological Analysis From 1990 to 2019, Archives of Orthopaedic and Trauma Surgery (2023)
10. Prevalence of Thyroid Dysfunction Among Iranian Older Adults: A Cross-Sectional Study, Scientific Reports (2023)
11. Global, Regional, and National Burden of Upper Respiratory Infections and Otitis Media, 1990–2021: A Systematic Analysis From the Global Burden of Disease Study 2021, The Lancet Infectious Diseases (2025)
12. Epidemiology, Burden, and Attributable Risks of Infective Endocarditis in Iran and Its Provinces: From 1990 to 2019, International Journal of Cardiology (2022)
13. Global, Regional, and National Burden of Hepatitis B, 1990–2019: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet Gastroenterology and Hepatology (2022)
14. Incident Type 2 Diabetes Attributable to Suboptimal Diet in 184 Countries, Nature Medicine (2023)
15. The Burden of Rheumatoid Arthritis and Low Back Pain in North Africa and Middle East From 1990 to 2019: Results From the Global Burden of Disease Study 2019, International Journal of Rheumatic Diseases (2023)
16. The Association Between Healthy Beverage Index and Psychological Disorders Among Overweight and Obese Women: A Cross-Sectional Study, BMC Women's Health (2022)
17. Burden of Tension-Type Headache in the Middle East and North Africa Region, 1990-2019, Journal of Headache and Pain (2022)
18. Global, Regional, and National Cancer Deaths and Disability-Adjusted Life-Years (Dalys) Attributable to Alcohol Consumption in 204 Countries and Territories, 1990-2019, Cancer (2022)
19. The Global Burden of Cancer Attributable to Risk Factors, 2010–19: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet (2022)
20. Burden of Ischemic Heart Disease and Its Attributable Risk Factors in 204 Countries and Territories, 1990-2019, European Journal of Preventive Cardiology (2022)
21. Assessing Performance of the Healthcare Access and Quality Index, Overall and by Select Age Groups, for 204 Countries and Territories, 1990–2019: A Systematic Analysis From the Global Burden of Disease Study 2019, The Lancet Global Health (2022)
22. Global, Regional, and National Mortality Due to Unintentional Carbon Monoxide Poisoning, 2000–2021: Results From the Global Burden of Disease Study 2021, The Lancet Public Health (2023)
23. Estimating the Burden of Atrial Fibrillation and Atrial Flutter With Projection to 2050 in Iran, Scientific Reports (2024)
24. Low Bone Mineral Density, a Neglected Condition in North Africa and Middle East: Estimates From the Global Burden of Disease Study, 1990–2019, Osteoporosis International (2023)
25. Estimation of the Global Prevalence of Dementia in 2019 and Forecasted Prevalence in 2050: An Analysis for the Global Burden of Disease Study 2019, The Lancet Public Health (2022)
26. Burden of Chronic Obstructive Pulmonary Disease and Its Attributable Risk Factors in 204 Countries and Territories, 1990-2019: Results From the Global Burden of Disease Study 2019, The BMJ (2022)
27. Global Incidence, Prevalence, Years Lived With Disability (Ylds), Disability-Adjusted Life-Years (Dalys), and Healthy Life Expectancy (Hale) for 371 Diseases and Injuries in 204 Countries and Territories and 811 Subnational Locations, 1990–2021: A Systematic Analysis for the Global Burden of Disease Study 2021, The Lancet (2024)
28. Global, Regional, and National Burden of Stroke and Its Risk Factors, 1990-2019: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet Neurology (2021)
29. Regional Burden of Chronic Kidney Disease in North Africa and Middle East During 1990–2019; Results From Global Burden of Disease Study 2019, Frontiers in Public Health (2022)
30. Maternal Urinary Iodine Concentration and Pregnancy Outcomes: Tehran Thyroid and Pregnancy Study, Biological Trace Element Research (2020)
31. Estimating Mortality and Disability in Peru Before the Covid-19 Pandemic: A Systematic Analysis From the Global Burden of the Disease Study 2019, Frontiers in Public Health (2023)
32. Global, Regional, and National Burden of Stroke and Its Risk Factors, 1990–2021: A Systematic Analysis for the Global Burden of Disease Study 2021, The Lancet Neurology (2024)
33. Injury Burden in Individuals Aged 50 Years or Older in the Eastern Mediterranean Region, 1990–2019: A Systematic Analysis From the Global Burden of Disease Study 2019, The Lancet Healthy Longevity (2022)
34. National and Subnational Survey on Diabetes Burden and Quality of Care Index in Iran: A Systematic Analysis of the Global Burden of Disease Study 1990–2019, Journal of Diabetes and Metabolic Disorders (2022)
35. Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019 a Systematic Analysis for the Global Burden of Disease Study 2019, JAMA Oncology (2022)
36. Measuring the Availability of Human Resources for Health and Its Relationship to Universal Health Coverage for 204 Countries and Territories From 1990 to 2019: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet (2022)
37. Global, Regional, and National Burden of Cancers Attributable to Excess Body Weight in 204 Countries and Territories, 1990 to 2019, Obesity (2022)
38. Prevalence, Years Lived With Disability, and Trends in Anaemia Burden by Severity and Cause, 1990–2021: Findings From the Global Burden of Disease Study 2021, The Lancet Haematology (2023)
39. Estimates of Incidence, Prevalence, Mortality, and Disability-Adjusted Life Years of Lung Cancer in Iran, 1990–2019: A Systematic Analysis From the Global Burden of Disease Study 2019, Cancer Medicine (2022)
40. Burden of Stroke in North Africa and Middle East, 1990 to 2019: A Systematic Analysis for the Global Burden of Disease Study 2019, BMC Neurology (2022)
41. Burden of Disease Scenarios for 204 Countries and Territories, 2022–2050: A Forecasting Analysis for the Global Burden of Disease Study 2021, The Lancet (2024)
42. Burden of Knee Osteoarthritis in the Middle East and North Africa (Mena): An Epidemiological Analysis From 1990 to 2019, Archives of Orthopaedic and Trauma Surgery (2023)
43. Global, Regional, and National Burden of Diabetes From 1990 to 2021, With Projections of Prevalence to 2050: A Systematic Analysis for the Global Burden of Disease Study 2021, The Lancet (2023)
44. Global Burden of Lower Respiratory Infections During the Last Three Decades, Frontiers in Public Health (2023)
45. Fatal Police Violence by Race and State in the Usa, 1980–2019: A Network Meta-Regression, The Lancet (2021)
46. Burden of Cancers Attributable to High Fasting Plasma Glucose in the Middle East and North Africa Region, 1990–2019, Cancer Medicine (2023)
47. Spatial, Temporal, and Demographic Patterns in Prevalence of Smoking Tobacco Use and Attributable Disease Burden in 204 Countries and Territories, 1990A€“2019: A Systematic Analysis From the Global Burden of Disease Study 2019, The Lancet (2021)
48. A 30-Year Trend of Ischemic Heart Disease Burden in a Developing Country; a Systematic Analysis of the Global Burden of Disease Study 2019 in Iran, International Journal of Cardiology (2023)
49. National and Subnational Burden of Stroke in Iran From 1990 to 2019, Annals of Clinical and Translational Neurology (2022)
50. Global, Regional, and National Burden of Disorders Affecting the Nervous System, 1990–2021: A Systematic Analysis for the Global Burden of Disease Study 2021, The Lancet Neurology (2024)